Special Drug Use-Results Survey of Corala
Not Applicable
Completed
- Conditions
- Chronic heart failure
- Registration Number
- JPRN-jRCT1080225341
- Lead Sponsor
- ONO PHARMACEUTICAL CO.,LTD.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- completed
- Sex
- All
- Target Recruitment
- 600
Inclusion Criteria
Patients will be registered as subjects in this survey if they are chronic heart failure patients with sinus rhythm and a resting heart rate of >=75 bpm at the initiation of the treatment who are receiving the standard of care for chronic heart failure, including beta-blockers, which is specified as indication of the drug, and they have no previous history of treatment with the drug.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method safety<br>Safety items : Occurrence of adverse drug reactions set as safety specifications, factors considered to influence the safety<br>Efficacy items : Resting heart rate, pulse rate, NYHA heart function class, left ventricular ejection fraction, left ventricular end-systolic volume, left ventricular end-diastolic volume, subjective symptoms (shortness of breath, swelling, frequent fatigue, decreased appetite, insomnia), BNP, NT-proBNP, factors considered to influence the efficacy
- Secondary Outcome Measures
Name Time Method